You searched for "teaching"
Efficacy of combined vitrectomy with intravitreal corticosteroid injection for ERM
1 December 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Dexamethasone, Epiretinal membrane, Intravitreal injection, Triamcinolone, Vitrectomy
In this study the authors evaluated the efficacy of vitrectomy combined with corticosteroid injection for idiopathic epiretinal membrane (ERM). A systematic literature review was conducted by searching three electronic databases, PubMed, Embase and Medline, up to 2020 for relevant studies....
Homonymous hemianopia due to stroke presenting symptoms and lesion locations
1 July 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
A retrospective case notes review was undertaken of patients diagnosed with homonymous hemianopia following a radiologically confirmed stroke. A total of 85 patients were identified by searching an electronic medical records system over an 11-year period. Data were extracted from...
VISION 2020 LINKS Programme: Reviewing the first ten years and announcing the new diabetic retinopathy initiative
1 April 2014
| Marcia Zondervan, Claire Walker, Nick Astbury, Allen Foster (Prof)
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - Refractive, EYE - General
The VISION 2020 LINKS Programme celebrates its 10th anniversary next month. Over the past decade it has achieved its objective of building capacity for eye care in developing countries, particularly in Africa, by establishing long-term training partnerships between institutions, known...
CHEC celebrates surgeon’s 1000th cataract surgery
Community healthcare provider marks Lancashire surgeon’s major milestone.Ophtherminator 3 - Rise of the Machines
“Bring back life form, priority one, all other priorities are rescinded.” Film buffs will spot this as a chilling quote spoken by Ash (Ian Holm) from the classic sci-fi horror movie Alien (1979). Ash (spoiler alert) is a Hyperdyne Systems...Saccades and contrast sensitivity in retinoblastoma survivors
The authors report a cross-sectional study, which recruited children aged 5 to 18 years old who completed treatment completion for retinoblastoma more than six months ago. Exclusion criteria included bilateral enucleation and pre-existing conditions associated with cognitive impairment. A total...Scope Eyecare Announces Winners of Independent Prescriber Bursary Awards 2022
2 August 2022
Three winners announced among 70 applicants.
AOP delivers world class education at record breaking 100% Optical
The AOP provided over 120 hours of CPD accredited sessions to thousands of delegates from 24 to 26 February.Surgeons can lead the way in transforming global health
Surgeons must provide leadership in transforming healthcare across the Global South – by integrating surgery into the global health agenda and advocating for simple and cost-effective surgical procedures that support overall health system strengthening.Clinical evaluation of a new pupil independent diffractive MIOL lens with a ±2.75D near addition
1 April 2016
| Jonathan Chan
|
EYE - Cataract, EYE - Refractive
|
Diagnostic tests/Investigation, Treatment Surgery, Vision
This is a clinical outcome assessment after cataract surgery with implantation of multifocal intraocular lens implant IOL with a lower near addition (+2.75D) of 143 eyes of 85 patients aged between 40 to 83 years of age. The type of...
Rebound phenomenon after IVT triamcinolone acetonide for macular oedema
7 April 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this retrospective study, the authors report the rebound phenomenon after intravitreal triamcinolone acetonide (IVTA) injection for macular oedema secondary to diabetic retinopathy (DR) and central (CRVO) or branch retinal vein occlusion (BRVO). The incidence of a rebound phenomenon was...
Presenting the new Surgitrac website!
11 April 2024
|
Company Profiles, Research & Development
We are thrilled to announce the launch of our brand-new website—crafted with our audience in mind.